1. Home
  2. DAKT vs BBIO Comparison

DAKT vs BBIO Comparison

Compare DAKT & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAKT
  • BBIO
  • Stock Information
  • Founded
  • DAKT 1968
  • BBIO 2015
  • Country
  • DAKT United States
  • BBIO United States
  • Employees
  • DAKT N/A
  • BBIO N/A
  • Industry
  • DAKT Office Equipment/Supplies/Services
  • BBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • DAKT Industrials
  • BBIO Health Care
  • Exchange
  • DAKT Nasdaq
  • BBIO Nasdaq
  • Market Cap
  • DAKT 710.0M
  • BBIO 8.0B
  • IPO Year
  • DAKT 1994
  • BBIO 2019
  • Fundamental
  • Price
  • DAKT $16.21
  • BBIO $46.47
  • Analyst Decision
  • DAKT Strong Buy
  • BBIO Strong Buy
  • Analyst Count
  • DAKT 1
  • BBIO 14
  • Target Price
  • DAKT $26.00
  • BBIO $60.21
  • AVG Volume (30 Days)
  • DAKT 506.5K
  • BBIO 3.3M
  • Earning Date
  • DAKT 09-03-2025
  • BBIO 07-31-2025
  • Dividend Yield
  • DAKT N/A
  • BBIO N/A
  • EPS Growth
  • DAKT N/A
  • BBIO N/A
  • EPS
  • DAKT N/A
  • BBIO N/A
  • Revenue
  • DAKT $756,477,000.00
  • BBIO $127,415,000.00
  • Revenue This Year
  • DAKT $9.98
  • BBIO $107.34
  • Revenue Next Year
  • DAKT $6.80
  • BBIO $49.48
  • P/E Ratio
  • DAKT N/A
  • BBIO N/A
  • Revenue Growth
  • DAKT N/A
  • BBIO N/A
  • 52 Week Low
  • DAKT $10.24
  • BBIO $21.72
  • 52 Week High
  • DAKT $19.89
  • BBIO $46.80
  • Technical
  • Relative Strength Index (RSI)
  • DAKT 59.38
  • BBIO 71.64
  • Support Level
  • DAKT $15.87
  • BBIO $41.80
  • Resistance Level
  • DAKT $16.78
  • BBIO $46.80
  • Average True Range (ATR)
  • DAKT 0.83
  • BBIO 1.44
  • MACD
  • DAKT 0.11
  • BBIO 0.09
  • Stochastic Oscillator
  • DAKT 78.02
  • BBIO 94.00

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: